Antiplatelet Therapy May Be Insufficient to Prevent Stroke Recurrence Before Percutaneous Patent Foramen Ovale Closure

참고문헌 (10)

1. Saver JL, "Long-term outcomes of patent foramen ovale closure or medical therapy after stroke", N Engl J Med, 377, pp.1022~1032 (2017)
2. Mas JL, "Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke", N Engl J Med, 377, pp.1011~1021 (2017)
3. Søndergaard L, "Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke", N Engl J Med, 377, pp.1033~1042 (2017)
4. Lee PH, "Cryptogenic stroke and high-risk patent foramen ovale : the DEFENSE-PFO trial", J Am Coll Cardiol, 71, pp.2335~2342 (2018)
5. Miyamoto S, "Japan Stroke Society guideline 2021 for the treatment of stroke", Int J Stroke, 17, pp.1039~1049 (2022)
6. Angelini F, "Comparison of antithrombotic strategies in patients with cryptogenic stroke and patent foramen ovale : an updated meta-analysis", Cardiovasc Drugs Ther, 35, pp.987~993 (2021)
7. Kent DM, "An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke", Neurology, 81, pp.619~625 (2013)
8. Diener HC, "Dabigatran or aspirin after embolic stroke of undetermined source in patients with patent foramen ovale : results from RE-SPECT ESUS", Stroke, 52, pp.1065~1068 (2021)
9. Elmariah S, "Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I(evaluation of the STARFlex septal closure system in patients with a stroke and", or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale)trial, 2014, pp.7, 913~920
10. Thaler DE, "Recurrent stroke predictors differ in medically treated patients with pathogenic vs. other PFOs", Neurology, 83, pp.221~226 (2014)

관련 논문AI추천